261 related articles for article (PubMed ID: 16596215)
1. Lactoferricin-induced apoptosis in estrogen-nonresponsive MDA-MB-435 breast cancer cells is enhanced by C6 ceramide or tamoxifen.
Furlong SJ; Mader JS; Hoskin DW
Oncol Rep; 2006 May; 15(5):1385-90. PubMed ID: 16596215
[TBL] [Abstract][Full Text] [Related]
2. Modulation of ceramide metabolism in T-leukemia cell lines potentiates apoptosis induced by the cationic antimicrobial peptide bovine lactoferricin.
Furlong SJ; Ridgway ND; Hoskin DW
Int J Oncol; 2008 Mar; 32(3):537-44. PubMed ID: 18292930
[TBL] [Abstract][Full Text] [Related]
3. Apoptosis induced by intracellular ceramide accumulation in MDA-MB-435 breast carcinoma cells is dependent on the generation of reactive oxygen species.
Chan SY; Hilchie AL; Brown MG; Anderson R; Hoskin DW
Exp Mol Pathol; 2007 Feb; 82(1):1-11. PubMed ID: 16624283
[TBL] [Abstract][Full Text] [Related]
4. Rationale for sequential tamoxifen and anticancer drugs in adjuvant setting for patients with node- and receptor-positive breast cancer.
Kim R; Tanabe K; Emi M; Uchida Y; Osaki A; Toge T
Int J Oncol; 2005 Apr; 26(4):1025-31. PubMed ID: 15753998
[TBL] [Abstract][Full Text] [Related]
5. Effect of loop structure of bovine lactoferricin on apoptosis in Jurkat cells.
Zhang TN; Yang W; Liu N
Biometals; 2010 Jun; 23(3):555-61. PubMed ID: 20237822
[TBL] [Abstract][Full Text] [Related]
6. Bovine lactoferricin induces caspase-independent apoptosis in human B-lymphoma cells and extends the survival of immune-deficient mice bearing B-lymphoma xenografts.
Furlong SJ; Mader JS; Hoskin DW
Exp Mol Pathol; 2010 Jun; 88(3):371-5. PubMed ID: 20171209
[TBL] [Abstract][Full Text] [Related]
7. beta-Sitosterol enhances tamoxifen effectiveness on breast cancer cells by affecting ceramide metabolism.
Awad AB; Barta SL; Fink CS; Bradford PG
Mol Nutr Food Res; 2008 Apr; 52(4):419-26. PubMed ID: 18338406
[TBL] [Abstract][Full Text] [Related]
8. Bovine lactoferricin causes apoptosis in Jurkat T-leukemia cells by sequential permeabilization of the cell membrane and targeting of mitochondria.
Mader JS; Richardson A; Salsman J; Top D; de Antueno R; Duncan R; Hoskin DW
Exp Cell Res; 2007 Jul; 313(12):2634-50. PubMed ID: 17570361
[TBL] [Abstract][Full Text] [Related]
9. Siegesbeckia glabrescens induces apoptosis with different pathways in human MCF-7 and MDA-MB-231 breast carcinoma cells.
Jun SY; Choi YH; Shin HM
Oncol Rep; 2006 Jun; 15(6):1461-7. PubMed ID: 16685380
[TBL] [Abstract][Full Text] [Related]
10. Tamoxifen and TRAIL synergistically induce apoptosis in breast cancer cells.
Lagadec C; Adriaenssens E; Toillon RA; Chopin V; Romon R; Van Coppenolle F; Hondermarck H; Le Bourhis X
Oncogene; 2008 Feb; 27(10):1472-7. PubMed ID: 17767197
[TBL] [Abstract][Full Text] [Related]
11. Novel ceramide analogs as potential chemotherapeutic agents in breast cancer.
Struckhoff AP; Bittman R; Burow ME; Clejan S; Elliott S; Hammond T; Tang Y; Beckman BS
J Pharmacol Exp Ther; 2004 May; 309(2):523-32. PubMed ID: 14742741
[TBL] [Abstract][Full Text] [Related]
12. Ceramide-induced cell death in lens epithelial cells.
Samadi A
Mol Vis; 2007 Sep; 13():1618-26. PubMed ID: 17893663
[TBL] [Abstract][Full Text] [Related]
13. C6-ceramide and targeted inhibition of acid ceramidase induce synergistic decreases in breast cancer cell growth.
Flowers M; Fabriás G; Delgado A; Casas J; Abad JL; Cabot MC
Breast Cancer Res Treat; 2012 Jun; 133(2):447-58. PubMed ID: 21935601
[TBL] [Abstract][Full Text] [Related]
14. The efficacy of tamoxifen in estrogen receptor-positive breast cancer cells is enhanced by a medical nutriment.
Marcsek Z; Kocsis Z; Jakab M; Szende B; Tompa A
Cancer Biother Radiopharm; 2004 Dec; 19(6):746-53. PubMed ID: 15665622
[TBL] [Abstract][Full Text] [Related]
15. In vitro and in vivo anti-angiogenic activities and inhibition of hormone-dependent and -independent breast cancer cells by ceramide methylaminoethylphosphonate.
Chintalapati M; Truax R; Stout R; Portier R; Losso JN
J Agric Food Chem; 2009 Jun; 57(12):5201-10. PubMed ID: 19476359
[TBL] [Abstract][Full Text] [Related]
16. Tanshinone I effectively induces apoptosis in estrogen receptor-positive (MCF-7) and estrogen receptor-negative (MDA-MB-231) breast cancer cells.
Nizamutdinova IT; Lee GW; Son KH; Jeon SJ; Kang SS; Kim YS; Lee JH; Seo HG; Chang KC; Kim HJ
Int J Oncol; 2008 Sep; 33(3):485-91. PubMed ID: 18695877
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of cyclooxygenase-2 and induction of apoptosis in estrogen-nonresponsive breast cancer cells by Antrodia camphorata.
Hseu YC; Chen SC; Tsai PC; Chen CS; Lu FJ; Chang NW; Yang HL
Food Chem Toxicol; 2007 Jul; 45(7):1107-15. PubMed ID: 17391824
[TBL] [Abstract][Full Text] [Related]
18. Liposomal delivery enhances short-chain ceramide-induced apoptosis of breast cancer cells.
Stover T; Kester M
J Pharmacol Exp Ther; 2003 Nov; 307(2):468-75. PubMed ID: 12975495
[TBL] [Abstract][Full Text] [Related]
19. Novel ceramide analogues display selective cytotoxicity in drug-resistant breast tumor cell lines compared to normal breast epithelial cells.
Crawford KW; Bittman R; Chun J; Byun HS; Bowen WD
Cell Mol Biol (Noisy-le-grand); 2003 Nov; 49(7):1017-23. PubMed ID: 14682383
[TBL] [Abstract][Full Text] [Related]
20. Tamoxifen and genistein synergistically down-regulate signal transduction and proliferation in estrogen receptor-negative human breast carcinoma MDA-MB-435 cells.
Shen F; Xue X; Weber G
Anticancer Res; 1999; 19(3A):1657-62. PubMed ID: 10470097
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
